The psychoactive constituent of cannabis, Δ 9 -tetrahydrocannabinol, produces in humans
subjective responses mediated by CB1 cannabinoid receptors, indicating that endogenous …

Although anecdotal reports suggest that cannabis may be used to alleviate symptoms of
depression, the psychotropic effects and abuse liability of this drug prevent its therapeutic …

This review summarizes gender differences (GDs) in drug response. Although GDs have been
described both in pharmacodynamics and pharmacokinetics, their role in clinical practice …

The association between fat consumption and obesity underscores the need to identify
physiological signals that control fat intake. Previous studies have shown that feeding stimulates …

Background and purpose: Pharmacological inhibition of beta‐amyloid (Aβ) induced reactive
gliosis may represent a novel rationale to develop drugs able to blunt neuronal damage …

Extensive evidence indicates that the basolateral complex of the amygdala (BLA) modulates
the consolidation of memories for emotionally arousing experiences, an effect that involves …

Space–time anomalies of Earth's emitted radiation in the thermal infrared spectral range (TIR)
measured from satellite months to weeks before the occurrence of earthquakes, have …

The aim of this study was to characterize nanoparticles (NPs) composed of chitosan (CS)
and evaluate their potential for brain delivery of the neurotransmitter Dopamine (DA). For this …

To investigate the possible long-term consequences of gestational exposure to cannabinoids
on cognitive functions, pregnant rats were administered with the CB1 receptor agonist WIN …

BACKGROUND: Social stress leads to oxidative stress in the central nervous system,
contributing to the development of mental disorders. Loss of parvalbumin in interneurons is an …